Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
about
The J-Curve Phenomenon in HypertensionPeroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitusDiabetes in older adultsBlood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)Diabetes in older adults: a consensus reportPrevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review.Target blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study.Physiological Changes in Older Adults and Their Effect on Diabetes Treatment.Impact of delaying blood pressure control in patients with Type 2 diabetes: results of a decision analysis.The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway.Monitoring performance for blood pressure management among patients with diabetes mellitus: too much of a good thing?Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials.Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database.Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002-2012 literature review.Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus.Blood pressure treatment target in patients with diabetes mellitus--current evidence.Do the socioeconomic and hypertension gradients in rural populations of low- and middle-income countries differ by geographical region? A systematic review and meta-analysis.Antihypertensive therapy and the J-curve: fact or fiction?Update on blood pressure control and renal outcomes in diabetes mellitus.Glucose targets for preventing diabetic kidney disease and its progression.Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension.Simultaneous pancreas-kidney transplantation for diabetic end-stage renal disease under a hypertension status.[Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?].[J curve: when lowering blood pressure becomes a hazard?].The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial.Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus.The Effect of Sanggua Drink Extract on Insulin Resistance through the PI3K/AKT Signaling Pathway.Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia—the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
P2860
Q26738834-2A375423-10B1-4B56-BB16-A17AC5950C37Q28258316-42A5A7C1-4BEB-498D-A5A9-29F8F0EB392EQ30528669-7332B7B7-9008-4CEF-9469-FBE75692A3B5Q34219430-A733C322-FB13-4508-B147-41F3FA61D1D0Q34308751-C9ED3BD5-6989-47FF-8221-40EC0368931DQ35003229-5B5B5BC4-03EC-4AA3-A1FF-8CE0ACC9F100Q35148838-EAC6D1A5-869C-4278-ACFA-6420D09F0B5CQ35166774-ED8EF83B-9F31-472B-9C76-155DF8D39927Q35910471-2310FFE6-596A-459C-8E0B-47F448F4A042Q35980715-3AFB6560-C4D8-4BD8-9B08-1E4D8CA4FD60Q36310328-09C94278-AF56-4698-A8A4-737E87E634D5Q36975426-958FEB37-FE4C-4BB9-9C27-B47358FC74E4Q37023878-A5D07AA6-8542-44D2-B091-3F8279A4C041Q37106533-B96E4E7E-3609-4F7A-B6FF-0A8A5E2AEBBEQ37320310-0F3FDFF5-83F9-4BE7-A5FA-40641920B712Q37689636-1C4F39B2-C7BB-48B5-A1D1-0C8067F225F6Q37961846-514FE6C5-6E4E-43AB-8D80-8B7BA329B0C8Q38020000-B6064F9D-5463-4C53-B450-E340834878A9Q38215425-8B7133CC-DEA6-4DE9-A2A9-5736CA335DD3Q38332286-903279C0-6D0A-40D1-AB78-4C12534B9841Q38492248-467AF239-0897-4C8D-B503-2FB9D2676858Q38736800-7F1586A6-77D1-45BE-8662-7FB69D02EE9CQ39262972-39AC8D09-6EEB-4CDB-8703-99CC2C959102Q43201026-7724474D-5039-422D-A1DC-A3C5E1D3C288Q43981382-54E081C4-A5CB-4826-91C8-DEAA09BD2AB3Q46763725-7632604B-F5C8-434B-970C-194C408EE522Q47805361-2BEE68D6-538A-425C-8A9A-73D3A45BBE34Q48799668-57106804-25C8-43B0-8D53-EFBFD7E52475Q55051778-CC5949D6-7E5B-4475-93BE-23E7813AEEB0Q57396155-6E960069-EBD8-4232-AF4A-204A845F6D9F
P2860
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@ast
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@en
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@nl
type
label
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@ast
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@en
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@nl
prefLabel
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@ast
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@en
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@nl
P2093
P2860
P356
P1433
P1476
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
@en
P2093
Carlos Abraira
Derrick Kaufman
Gideon D Bahn
Robert J Anderson
Thomas E Moritz
VADT Study Group
William Duckworth
P2860
P356
10.2337/DC10-1420
P407
P577
2010-11-08T00:00:00Z